The diabetes and weight loss drugs are “not cost-effective at their current prices, and are largely unavailable to people with lower incomes,” the report said.

Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

Prescription drug spending in the United States rose by 10.2% last year, thanks in part to the popularity of GLP weight-loss ...

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...

While GLP-1 receptor agonists and bariatric surgery offer significant metabolic benefits, experts caution that rapid weight ...

The U.S. Food and Drug Administration (FDA) has issued a warning to patients and healthcare professionals regarding the use ...

This article was provided by Mary Washington Healthcare, a corporate sponsor of the Fredericksburg Free Press. As part of its ...